Association of Macrophage Migration Inhibitory Factor Gene Promoter Polymorphisms with Multiple Sclerosis in Turkish Patients

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of International Medical Research

• Publication date

  2010-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1177/147323001003800108PMID 20233515
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Th17 Cells in MS and Experimental Autoimmune Encephalomyelitis.

  2009cited by this paper
• Association of MIF promoter polymorphisms with childhood asthma in a northeastern Chinese population.

  2009cited by this paper
• Macrophage-migration inhibitory factor: role in inflammatory diseases and graft rejection

  2008cited by this paper
• Genetic epidemiology: the use of old and new tools for multiple sclerosis.

  2008cited by this paper
• Risk Alleles for Multiple Sclerosis Identified by a Genomewide Study

  2008cited by this paper
• Risk alleles for multiple sclerosis identified by a genomewide study.

  2007cited by this paper
• Multiple Sclerosis

  2007cited by this paper
• Macrophage migration inhibitory factor gene: influence on rheumatoid arthritis susceptibility.

  2007cited by this paper
• Variation in interleukin 7 receptor α chain (IL7R) influences risk of multiple sclerosis

  2007cited by this paper
• New therapeutic target in inflammatory disease: macrophage migration inhibitory factor

  2005cited by this paper
• Correlation of rheumatoid arthritis severity with the genetic functional variants and circulating levels of macrophage migration inhibitory factor.

  2005cited by this paper
• Genetics of multiple sclerosis.

  2004cited by this paper
• Association of the −173 G/C polymorphism of the macrophage migration inhibitory factor gene with ulcerative colitis

  2004cited by this paper
• Premalignant lesions of the kidney share the same genetics changes as conventional renal cell carcinoma

  2004cited by this paper
• Regulation of p53 by macrophage migration inhibitory factor in inflammatory arthritis.

  2003cited by this paper
• Macrophage migration inhibitory factor: a regulator of innate immunity

  2003cited by this paper
• Macrophage migration inhibitory factor: an emerging therapeutic target in rheumatoid arthritis.

  2003cited by this paper
• In Vivo Blockade of Macrophage Migration Inhibitory Factor Ameliorates Acute Experimental Autoimmune Encephalomyelitis by Impairing the Homing of Encephalitogenic T Cells to the Central Nervous System

  2003cited by this paper
• Functional and prognostic relevance of the -173 polymorphism of the macrophage migration inhibitory factor gene in systemic-onset juvenile idiopathic arthritis.

  2003cited by this paper
• Development of chronic colitis is dependent on the cytokine MIF

  2002cited by this paper
• Macrophage migration inhibitory factor gene polymorphism is associated with sarcoidosis in biopsy proven erythema nodosum.

  2002cited by this paper
• Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis

  2001cited by this paper
• Development of chronic colitis is dependent on the cytokine MIF

  2001cited by this paper
• Role of macrophage migration inhibitory factor (MIF) in murine antigen‐induced arthritis: interaction with glucocorticoids

  2001cited by this paper
• Expression and glucocorticoid regulation of macrophage migration inhibitory factor (MIF) in hippocampal and neocortical rat brain cells in culture.

  2000cited by this paper
• Multiple sclerosis.

  2000cited by this paper
• Macrophage migration inhibitory factor in the cerebrospinal fluid of patients with conventional and optic-spinal forms of multiple sclerosis and neuro-Behçet’s disease

  2000cited by this paper
• Identification of macrophage migration inhibitory factor mRNA expression in neural cells of the rat brain by in situ hybridization.

  1998cited by this paper
• Identification of macrophage migration inhibitory factor (MIF) in human vascular endothelial cells and its induction by lipopolysaccharide.

  1998cited by this paper
• Genetics of multiple sclerosis.

  1997cited by this paper
• Multiple Sclerosis: A Coordinated Immunological Attack against Myelin in the Central Nervous System

  1996cited by this paper
• An essential regulatory role for macrophage migration inhibitory factor in T-cell activation.

  1996cited by this paper
• De Novo renal expression of macrophage migration inhibitory factor during the development of rat crescentic glomerulonephritis.

  1996cited by this paper
• A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H‐2b mice: Fine specificity and T cell receptor Vβ expression of encephalitogenic T cells

  1995cited by this paper
• MIF as a glucocorticoid-induced modulator of cytokine production

  1995cited by this paper
• MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia

  1995cited by this paper
• The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor

  1994cited by this paper
• HLA class II-associated genetic susceptibility in multiple sclerosis: a critical evaluation.

  1991cited by this paper
• A simple salting out procedure for extracting DNA from human nucleated cells.

  1988cited by this paper

• MIF contribution to progressive brain diseases

  2024cites this paper
• Analysis of Macrophage Migration Inhibitory Factor Genotype in Hemophilia a Patients.

  2023cites this paper
• "Near Cure" treatment of severe acute EAE in MIF-1-deficient female and male mice with a bifunctional MHCII-derived molecular construct.

  2022cites this paper
• Brief report: Enhanced DRα1-mMOG-35-55 treatment of severe EAE in MIF-1-deficient male mice.

  2021cites this paper
• The MIF rs755622 Variant may Increase Susceptibility of Breast Cancer but not Gastrointestinal Cancer in a Turkish Population

  2020cites this paper
• Role of MIF -173G/C and Mbl2 codon 54A/B variants in risk of multiple myeloma: An association study.

  2020cites this paper
• Contribution of the macrophage migration inhibitory factor superfamily of cytokines in the pathogenesis of preclinical and human multiple sclerosis: In silico and in vivo evidences.

  2018cites this paper
• Genetic Variant rs755622 Regulates Expression of the Multiple Sclerosis Severity Modifier D-Dopachrome Tautomerase in a Sex-Specific Way

  2018cites this paper
• Roles of macrophage migration inhibitory factor in Guillain-Barré syndrome and experimental autoimmune neuritis: beneficial or harmful?

  2018cites this paper
• MIF functional polymorphisms (-794 CATT5-8 and -173 G>C) are associated with MIF serum levels, severity and progression in male multiple sclerosis from western Mexican population.

  2018cites this paper
• Macrophage migration inhibitory factor (MIF) modulates trophic signaling through interaction with serine protease HTRA1

  2017cites this paper
• Chemokines and cytokines on the neuroimmunoaxis: Inner ear neurotrophic cytokines in development and disease. Prospects for repair?

  2017cites this paper
• MIF Family Cytokines in Innate Immunity and Homeostasis

  2017influential citation
• Elevated Levels of Proinflammatory Cytokines in Cerebrospinal Fluid of Multiple Sclerosis Patients

  2017cites this paper
• Polymorphisms of RPS6KB1 and CD86 associates with susceptibility to multiple sclerosis in Iranian population

  2017cites this paper
• Non-significant influence of macrophage migration inhibitory factor (MIF) promoter gene polymorphisms on the risk or activity of Egyptian Behçet’s disease patients: Potential role of MIF+254T/C in posterior uveitis

  2017cites this paper
• Role of MIF in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis

  2017cites this paper
• MBL2 and MIF gene polymorphisms in cardiovascular patients with atherosclerotic lesions undergoing heart valve replacement

  2017cites this paper
• Syddansk Universitet Macrophage migration inhibitory factor ( MIF ) modulates trophic signaling through interaction with serine protease HTRA 1

  2017cites this paper
• MIF and D-DT are potential disease severity modifiers in male MS subjects

  2017cites this paper
• Macrophage Migration Inhibitory Factor Polymorphism Is Associated with Susceptibility to Inflammatory Coronary Heart Disease

  2015cites this paper
• Lack of association between MIF gene -173G>C polymorphism with multiple sclerosis.

  2015influential citation
• Influence of molecular genetics in Vogt-Koyanagi-Harada disease

  2014cites this paper
• Influence of molecular genetics in Vogt-Koyanagi-

  2014cites this paper
• MIF gene polymorphisms confer susceptibility to Vogt-Koyanagi-Harada syndrome in a Han Chinese population.

  2013cites this paper
• Association between MIF gene variation and Meniere's disease

  2013influential citation
• The polymorphisms of the MBL2 and MIF genes associated with Pediatric Cochlear Implant Patients.

  2013cites this paper
• Macrophage migration inhibitory factor gene polymorphism is not associated with pemphigus vulgaris in Iranian patients

  2013cites this paper
• Association of macrophage migration inhibitory factor gene polymorphisms with Behçet's disease in a Han Chinese population.

  2012cites this paper
• Investigating Alternative Splicing and Polyadenylation of the Interleukin 7 Receptor (IL7R) Exon 6: Implications for Multiple Sclerosis

  2012cites this paper
• Mannose Binding Lectin and Macrophage Migration Inhibitory Factor Gene Polymorphisms in Turkish Children with Cardiomyopathy: No Association with MBL2 Codon 54 A/B Genotype, but an Association between MIF -173 CC Genotype

  2012cites this paper
• Association of macrophage migration inhibitory factor and mannose-binding lectin-2 gene polymorphisms in acute rheumatic fever

  2012cites this paper
• D-dopachrome tautomerase (D-DT or MIF-2): doubling the MIF cytokine family.

  2012cites this paper
• Current world literature.

  2011cites this paper
• MIF as a disease target: ISO-1 as a proof-of-concept therapeutic.

  2011cites this paper
• Brain inflammation following stroke and cardiac arrest-Restraining neuroinflammation and subsequent psychiatric disorders

  2010cites this paper